Friday, January 11, 2008
Invitrogen Acquires CellzDirect
Carlsbad-based Invitrogen, a developer of life science technology, said Thursday that it has acquired CellzDirect, a provivder of services used in the testing of new drugs, for approximately $57M in cash. CellzDirect, which is based in Research Triangle Park, North Carolina, provides hepatocyte-based cell products and related services, which is used for predicting the effect of drugs on the liver. Invitrogen said that CellzDirect expects to have revenues of approximately $18M in calendar year 2007.
Get More SocalTech Data
Try our two week free trial to find new tech customers, find high tech startups and jobs, find venture funding, and more!Learn More